+390677209020 | +39 0267380552 info@direnzo.biz | sedemilano@direnzo.biz | Italian Language

Cybersecurity: the Impact of Legislative Decree4 September 2024 no. 138 on Medical Device Manufacturers

Cybersecurity in Medical Device

Legislative Decree 4 September 2024, no. 138, adopting Directive (EU) 2022/2555 (NIS 2), introduces important obligations on the subject of cybersecurity for companies operating in critical sectors, including medical devices.

The goal of the legislation is to ensure a high level of cybersecurity for infrastructures and products, minimising the risks of cyberattacks and protecting the health of patients as well as the safety of health operators.

General obligations for medical device manufacturers

Medical device manufacturers are bound to adopt suitable measures to ensure the safety of their products under the cyber profile.

This means to implement policies and tools for risk management, ensure sensible data protection and adopt security protocols preventing any possible vulnerability. In case of security incidents that may compromise the device reliability or availability, companies must promptly notify the National Cybersecurity Agency (ACN) within the timelines established by the regulations.

Another fundamental aspect concerns the security of the supply chain. Manufacturers must verify that their suppliers comply with adequate security standards, to prevent that any fault in the systems of third parties may compromise the security of the medical devices put on the market.

Moreover, a steady commitment is required in the personnel’s training, so that the operators involved in the design, manufacturing and maintenance of the devices are able to recognize and manage any cyber threat. 

The exemptions for small-sized enterprises and their implications

Article 3 of Legislative Decree 138/2024 establishes that micro- and small-sized enterprises, according to the definition of Recommendation 2003/361/EC, can benefit from specific exemptions from the obligations provided for by the regulations.

To fall into the category of small-sized enterprise, a company should have less than 50 employees and an annual turnover or a balance sheet total not exceeding 10 million euros.

However, such exemption is not unconditional

If small-sized enterprises operate in critical sectors or if the device they produce are considered essential for public safety or for the citizens’ health, they can be subject to specific obligations anyway.

This is the case of medical devices whose malfunctioning or impairment could significantly affect people’s life and stability of the health system, including vital support devices such as pacemakers, lung ventilators and infusion pumps; critical diagnostic instruments such as MRI and CT scanners; and remote monitoring devices used in hospitals and at home.

This category also includes the devices used by crucial health facilities, such as clinical data management systems, that could be the target of cyberattacks with serious consequences on the continuity of health assistance.

The Decree of the President of the Ministry Council 9 December 2024, no. 221, establishes the criteria for the application of the exemptions, ensuring that cyber protection is always suitable, also in case of small-sized entities.

Strategies for small-sized enterprise adaptation

Small-sized enterprises manufacturing medical devices needs to carefully consider the risks related to cyber security and adopt measures that are proportional to the nature and level of criticality of their products.

Though not obliged to comply with all the provisions in place for big-sized companies, it is advisable that they implement appropriate protection systems, ensure adequate training for their staff on the management of cyber threats, and keep themselves updated on the regulatory evolution on the subject of cybersecurity.

An effective approach could include the cooperation with external cybersecurity experts, taking part to dedicated initiatives aimed at sharing knowledge and resources to face the new challenges of digitalization.

Besides, a close collaboration with ACN and other regulatory authorities can ensure appropriate balance between the need of regulatory compliance and the actual capacity of small-sized companies to bear the burden of the provided obligations.

In conclusion

The adaptation to Legislative Decree 138/2024 is an important challenge for medical device manufacturers, regardless the size of their company. If complex cyber security policies are provided for for big-sized enterprises, that need to be continuously updated to the regulations, small-sized enterprises must carefully evaluate whether they are entitled to the provided exemptions. If the latter are not applicable, they have to adopt suitable measures to ensure the protection of their devices and data.

In a landscape that is more and more digitalized and interconnected, cyber security cannot be neglected, especially in a sphere as delicate as medical devices’.